Zydus Cadila has received an approval from the USFDA to market Tamsulosin capsules, 0.4 mg. Tamsulosin falls in the urology segment and is indicated for the treatment of Benign Prostatic Hyperplasia.
Zydus Cadila receives approval for Tamsulosin capsules